 |
|
| Blog results | Results 1 - 10 of about 1,089 for lupron depot for prostate cancer. (0.39 seconds) |
| Sorted by relevance Sort by date |
| 23 hours ago Degarelix (FIRMAGON(R)) Vs Leuprolide (Lupron Depot(R)) In Patients With Advanced Prostate Cancer: Further Analysis From A Phase III Pivotal Trial. Biotechnology news · Pharma Industry News. Drs. Neal Shore and E. David Crawford ... Pharmainfo.net - Pharma Industry News - http://www.pharmainfo.net/taxonomy/term/2747/0 |
| 23 hours ago by admin Degarelix (FIRMAGON(R)) Vs Leuprolide (Lupron Depot(R)) In Patients With Advanced Prostate Cancer: Further Analysis From A Phase III Pivotal Trial. Drs. Neal Shore and E. Here is the original post: Degarelix (FIRMAGON(R)) Vs Leuprolide ... The Medical Information Bank - http://www.theinfobank.net/ [ More results from The Medical Information Bank ] |
| 3 Dec 2009 We spoke to Derrick and his wife, Rachelle, for our first story on Lupron Depot. "There's days that I panic and my husband has to come home because I feel like I'm gonna die," Rachelle explains. This highly toxic cancer drug is prescribed to chemically castrate men dying from prostate cancer, to relieve pain in women suffering from endometriosis, for infertility, and even for children with early puberty. "I want to stop the next man, woman or child from taking this drug," ... KTNV - KTNV Local News Headlines - http://www.ktnv.com/global/category.asp?c=87059 - References [ More results from KTNV - KTNV Local News Headlines ] |
| 4 Dec 2009 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial. Pharma Industry News. BETHESDA, Md., Dec. 4 /PRNewswire/ -- Drs. Neal Shore and E. David ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 23 hours ago by Pharma Industry / Biotech Industry News... Degarelix (FIRMAGON(R)) Vs Leuprolide (Lupron Depot(R)) In Patients With Advanced Prostate Cancer: Further Analysis From A Phase III Pivotal Trial. Filed under: Uncategorized — Pharma Industry / Biotech Industry News From Medical News ... Uninsured RX - http://www.uninsuredrx.com/ |
| 19 hours ago by Jeff Daas Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of. The Cancer Foundation For The World - http://www.thecancerfoundationfortheworld.org/site/ [ More results from The Cancer Foundation For The World ] |
| 8 Nov 2009 by airblowguns Lupron Depot 3.75 approved, in combination with iron, for presurgical treatment of anemia caused by uterine fibroids. Lupron Depot-3 Month 22.5 mg approved for palliative treatment of advanced prostate cancer. CaPSURETM introduced. ... air blow guns - http://airblowguns.edublogs.org/ |
| 5 hours ago by admin Degarelix (FIRMAGON(R)) Vs Leuprolide (Lupron Depot(R)) In Patients With Advanced Prostate Cancer: Further Analysis From A Phase III Pivotal Trial. Author: admin. 6 Dec. Drs. Neal Shore and E. David Crawford presented results for ... www.pharmablog.nl - http://pharmablog.nl/ |
| 17 Nov 2009 You should intravenously prostate cancer and casodex 50 lupron if you are profound to stimulant or full risks reproductive as hormone (suprefact, suprecor), class (zoladex), click (supprelin), phobia (synarel), or if you have ... Swine Flu X Forum - http://swineflux.com/forum/ [ More results from Swine Flu X Forum ] |
| 9 Nov 2009 by admin My father was diagnosed with metastatic prostate cancer in 2000. At that time, his PSA was 250 and the cancer had already spread to his bones. He began hormone therapy treatment (Lupron Depot and Casodex) and his PSA dropped to less ... Prostate Cancer Blog - http://prostatecancercommunity.com/blog/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
